Dexbrompheniramine and phenylephrine and Kisqali (600 MG Dose)
Determining the interaction of Dexbrompheniramine and phenylephrine and Kisqali (600 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine and phenylephrine-Kisqali Femara Co-Pack
- Dexbrompheniramine and phenylephrine-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Dexbrompheniramine and phenylephrine-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Dexbrompheniramine and phenylephrine-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Dexbrompheniramine and phenylephrine-Kitabis Pak
- Dexbrompheniramine and phenylephrine-Kitabis Pak inhalation
- Kisqali (600 MG Dose)-Dexbrompheniramine and Phenylephrine Syrup
- Kisqali (600 MG Dose)-Dexbrompheniramine and Phenylephrine Tablets
- Kisqali (600 MG Dose)-Dexbrompheniramine and pseudoephedrine
- Kisqali (600 MG Dose)-Dexbrompheniramine and Pseudoephedrine Solution
- Kisqali (600 MG Dose)-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Kisqali (600 MG Dose)-Dexbrompheniramine and Pseudoephedrine Tablets